Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The Role of the Stem Cells Therapy in the Peripheral Artery Disease

Biscetti F., Bonadia N., Nardella E., Cecchini AL., Landolfi R., Flex A.

Narrative Review on Type 2 Diabetes, Peripheral Artery Disease, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Mol Sci (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31067647
PMCID
PMC6539394
DOI
10.3390/ijms20092233
Citations
9

Abstract (original English)

Vascular complications of diabetes mellitus are an important issue for all clinicians involved in the management of this complex pathology. Although many therapeutic advances have been reached, peripheral arterial disease is still an unsolved problem that each year compromises the quality of life and life span of affected patients. Oftentimes, patients, after ineffective attempts of revascularization, undergo greater amputations. At the moment, there is no effective and definitive treatment available. In this scenario, the therapeutic use of stem cells could be an interesting option. The aim of the present review is to gather all the best available evidence in this regard and to define a new role of the stem cells therapy in this field, from biomarker to possible therapeutic target.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Pluripotent Stem CellsAnimalsHumansDiabetic AngiopathiesStem Cell TransplantationClinical Trials as TopicPeripheral Arterial Disease

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research